Tubeimoside Ⅰ targets sodium/potassium ATPase alpha 1 subunit to selectively eliminate senescent cells and alleviate aging-associated abnormalities.
Abstract
Senescent cells accumulate with age and contribute to age-related diseases, which makes their selective elimination a promising strategy for therapeutic intervention. Tubeimoside I (TBMS1), a natural triterpenoid saponin derived from Bolbostemma paniculatum, has been extensively studied for its anticancer properties. However, its potential role as a senolytics has yet to be determined.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Tubeimoside I selectively eliminates senescent cells by targeting the sodium/potassium ATPase alpha 1 subunit, thereby alleviating aging-associated abnormalities. This represents an incremental advance in the senolytic field, identifying a specific natural compound and mechanism, but lacks the transformative novelty or robust in vivo lifespan extension data required for higher impact.
Author of this paper? Send a correction.